{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:38:29Z","timestamp":1789843109027,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005275","name":"Capital Region of Denmark","doi-asserted-by":"publisher","award":["R25-A2701"],"award-info":[{"award-number":["R25-A2701"]}],"id":[{"id":"10.13039\/501100005275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.psychres.2019.02.017","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T01:54:35Z","timestamp":1549763675000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2\/3 receptor blockade \u2013 An exploratory study"],"prefix":"10.1016","volume":"274","author":[{"given":"Signe W.","family":"D\u00fcring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette \u00d8.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte Y.","family":"Glenth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2590-5055","authenticated-orcid":false,"given":"Bj\u00f8rn H.","family":"Ebdrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.psychres.2019.02.017_bib0001","first-page":"9","article-title":"Assessing depression in schizophrenia, the Calgary Depression Scale","volume":"3","author":"Addington","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0002","first-page":"137","article-title":"Sexual dysfunction in male schizophrenic patients","volume":"56","author":"Aizenberg","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01614576.1976.11074483","article-title":"The PLISSIT model, A proposed conceptual scheme for the behavioral treatment of sexual problems","volume":"2","author":"Annon","year":"1976","journal-title":"J. Sex Educ. Therapy"},{"key":"10.1016\/j.psychres.2019.02.017_bib0004","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.pnpbp.2010.02.019","article-title":"Hyperprolactinaemia in early psychosis not only due to antipsychotics","volume":"34","author":"Aston","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hup.924","article-title":"Sexual dysfunction in schizophrenia, focus on recent evidence","volume":"23","author":"Baggaley","year":"2008","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.02.017_bib0051","doi-asserted-by":"crossref","first-page":"e1087","DOI":"10.1038\/tp.2017.59","article-title":"Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology","volume":"7","author":"Bak","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0006","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1373\/clinchem.2008.105312","article-title":"Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol, evaluation and validation on common immunoassay platforms","volume":"54","author":"Beltran","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.psychres.2019.02.017_bib0007","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/09513590.2015.1017810","article-title":"Hyperprolactinemia, pathophysiology and therapeutic approach","volume":"31","author":"Capozzi","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.psychres.2019.02.017_bib0008","doi-asserted-by":"crossref","first-page":"505","DOI":"10.31887\/DCNS.2014.16.4\/mcarbon","article-title":"Clinical predictors of therapeutic response to antipsychotics in schizophrenia","volume":"16","author":"Carbon","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.psychres.2019.02.017_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2015.05.014","article-title":"Postprandial prolactin suppression appears absent in antipsychotic-treated male patients","volume":"60","author":"Coello","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"Pt 2","key":"10.1016\/j.psychres.2019.02.017_bib0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2015.06.031","article-title":"Obesity and late-onset hypogonadism","volume":"418","author":"Corona","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.psychres.2019.02.017_bib0011","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/schbul\/sbv001","article-title":"The facts about sexual (dys) function in schizophrenia, an overview of clinically relevant findings","volume":"41","author":"de Boer","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.02.017_bib0012","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1038\/npp.2014.152","article-title":"Effects of dopamine D2\/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients","volume":"39","author":"During","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2019.02.017_bib0013","doi-asserted-by":"crossref","first-page":"yv109","DOI":"10.1093\/ijnp\/pyv109","article-title":"Effects of blocking D2\/D3 Receptors on mismatch negativity and P3a amplitude of initially antipsychotic naive, first episode schizophrenia patients","volume":"19","author":"During","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.02.017_bib0014","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1503\/jpn.150030","article-title":"Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2\/3 receptor blockade","volume":"41","author":"Ebdrup","year":"2016","journal-title":"J Psychiatry Neurosci."},{"key":"10.1016\/j.psychres.2019.02.017_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033291718003781","article-title":"Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-na\u00efve schizophrenia patients","volume":"18","author":"Ebdrup","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.02.017_bib0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.fertnstert.2016.12.018","article-title":"Effects of age on fertility and sexual function","volume":"107","author":"Eisenberg","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.psychres.2019.02.017_bib0050","first-page":"74","article-title":"Effect of adjunctive aripiprazole on sexual dysfunction in schizophrenia: A preliminary open-label study","volume":"50","author":"Fujioi","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0016","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/BF03345805","article-title":"Growth hormone, prolactin, and sexuality","volume":"35","author":"Galdiero","year":"2012","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.psychres.2019.02.017_bib0017","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4088\/JCP.v68n0302","article-title":"Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder","volume":"68","author":"Howes","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0018","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/00048674.2011.589044","article-title":"Antipsychotic-induced hyperprolactinaemia","volume":"45","author":"Inder","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0053","first-page":"1","article-title":"The impact of schizophrenia and intelligence on the relationship between age and brain volume","volume":"5","author":"Jensen","year":"2018","journal-title":"Schizophr. Res. Cogn."},{"key":"10.1016\/j.psychres.2019.02.017_bib0019","first-page":"1","article-title":"Cortical structures and their clinical correlates in antipsychotic-n+\u00e4ive schizophrenia patients before and after 6 weeks of dopamine D 2\/3 receptor antagonist treatment","volume":"8","author":"Jessen","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.02.017_bib0054","first-page":"2451","article-title":"Patterns of cortical structures and cognition in antipsychotic-na\u00efve patients with first-episode schizophrenia: A partial least squares correlation analysis","volume":"25","author":"Jessen","year":"2018","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.psychres.2019.02.017_bib0020","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2147\/NDT.S84528","article-title":"The influence of atypical antipsychotic drugs on sexual function","volume":"11","author":"Just","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2019.02.017_bib0021","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(18)30252-9","article-title":"Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE), a three-phase switching study","volume":"5","author":"Kahn","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0022","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.02.017_bib0023","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/oxfordjournals.schbul.a007130","article-title":"Sexuality and schizophrenia, a review","volume":"30","author":"Kelly","year":"2004","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.02.017_bib0024","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.psyneuen.2008.02.008","article-title":"Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin?","volume":"33","author":"Knegtering","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2019.02.017_bib0025","first-page":"419","article-title":"Hyperprolactinemia after low dose of amisulpride","volume":"25","author":"Kopecek","year":"2004","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.psychres.2019.02.017_bib0026","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.psyneuen.2011.04.007","article-title":"Prolactin in response to acute psychosocial stress in healthy men and women","volume":"36","author":"Lennartsson","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2019.02.017_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale, a new comprehensive rating scale for psychotropic drugs and a crosssectional study of side effects in neuroleptic treated patients","volume":"76","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatri. Scand."},{"key":"10.1016\/j.psychres.2019.02.017_bib0028","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/JCP.0b013e3182199bcc","article-title":"Sexual dysfunction in first-episode schizophrenia patients, results from European First Episode Schizophrenia Trial","volume":"31","author":"Malik","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.02.017_bib0029","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/me.2013-1349","article-title":"Minireview, Extrapituitary prolactin, an update on the distribution, regulation, and functions","volume":"28","author":"Marano","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.psychres.2019.02.017_bib0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1192\/bjp.bp.111.101220","article-title":"Sexual dysfunction in people with prodromal or first-episode psychosis","volume":"201","author":"Marques","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0031","first-page":"217","article-title":"Sexual dysfunction factors in patients with schizophrenia treated with second generation antipsychotics, not only prolactin","volume":"46","author":"Martin","year":"2018","journal-title":"Actas espanolas de psiquiatria"},{"key":"10.1016\/j.psychres.2019.02.017_bib0032","first-page":"141","article-title":"Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions","volume":"28","author":"Montejo","year":"2000","journal-title":"Actas espanolas de psiquiatria"},{"key":"10.1016\/j.psychres.2019.02.017_bib0033","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1111\/j.1743-6109.2010.01709.x","article-title":"Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics","volume":"7","author":"Montejo","year":"2010","journal-title":"J. Sex Med."},{"key":"10.1016\/j.psychres.2019.02.017_bib0034","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archgenpsychiatry.2012.847","article-title":"Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia","volume":"69","author":"Nielsen","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0035","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2012.02.007","article-title":"Alterations of the brain reward system in antipsychotic naive schizophrenia patients","volume":"71","author":"Nielsen","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0036","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamapsychiatry.2015.2582","article-title":"Striatal reward activity and antipsychotic-associated weight change in patients with schizophrenia undergoing initial treatment","volume":"73","author":"Nielsen","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0037","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jamapsychiatry.2014.16","article-title":"A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders","volume":"71","author":"Pedersen","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0038","first-page":"421","article-title":"The effects of novel and newly approved antipsychotics on serum prolactin levels, a comprehensive review","volume":"28","author":"Peuskens","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2019.02.017_bib0039","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1017\/S0033291713000226","article-title":"Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis","volume":"43","author":"Riecher-Rossler","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.02.017_bib0040","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/JCP.0000000000000539","article-title":"How hyperprolactinemia affects sexual function in patients under antipsychotic treatment","volume":"36","author":"Rubio-Abadal","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.02.017_bib0041","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12020-014-0254-6","article-title":"Endocrine evaluation of erectile dysfunction","volume":"46","author":"Sansone","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.psychres.2019.02.017_bib0042","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.psychres.2004.01.010","article-title":"Serum prolactin levels in unmedicated first-episode and recurrent schizophrenia patients, a possible marker for the disease's subtypes","volume":"127","author":"Segal","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2019.02.017_bib0043","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/YIC.0b013e328341e434","article-title":"A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics","volume":"26","author":"Serretti","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.02.017_bib0044","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-2007-981480","article-title":"Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication","volume":"40","author":"Westheide","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2019.02.017_bib0045","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/schbul\/sbu220","article-title":"Striatal D(2\/3) Binding potential values in drug-naive first-episode schizophrenia patients correlate with treatment outcome","volume":"41","author":"Wulff","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.02.017_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033291718004099","article-title":"The relation between dopamine D2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients","volume":"15","author":"Wulff","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.02.017_bib0046","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ecl.2013.06.003","article-title":"Drug addiction and sexual dysfunction","volume":"42","author":"Zaazaa","year":"2013","journal-title":"Endocrinol. Metab. Clin. North Am."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118318109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118318109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T06:04:15Z","timestamp":1606457055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178118318109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":52,"alternative-id":["S0165178118318109"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.02.017","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2\/3 receptor blockade \u2013 An exploratory study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}